HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity.

Abstract
We have recently shown that galactocerebroside (Gal-C)-expressing oligodendrocytes are highly vulnerable to (AMPA)/kainate receptor-mediated death. Here we examined the vulnerability of cells at different developmental stages of the oligodendrocyte lineage to AMPA/kainate receptor-mediated excitotoxicity. Oligodendrocyte precursor cells, pre-oligodendrocytes and mature oligodendrocytes were killed by 24 h exposures to low concentrations of kainate (30-100 microM). Death was attenuated by the AMPA/kainate receptor antagonist 6-nitro-7-sulfamoylbenzo(f)quinoxaline-2,3-dione (NBQX). The high vulnerability of oligodendrocytes and their precursors to AMPA/kainate receptor excitotoxicity may represent an important mechanism of white matter damage resulting from trauma or ischemia in the perinatal and adult central nervous system (CNS).
AuthorsJ W McDonald, J M Levine, Y Qu
JournalNeuroreport (Neuroreport) Vol. 9 Issue 12 Pg. 2757-62 (Aug 24 1998) ISSN: 0959-4965 [Print] England
PMID9760116 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Excitatory Amino Acid Antagonists
  • Excitatory Amino Acids
  • Quinoxalines
  • Receptors, AMPA
  • Receptors, Kainic Acid
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
Topics
  • Animals
  • Astrocytes (physiology)
  • Cell Lineage (drug effects, physiology)
  • Coculture Techniques
  • Excitatory Amino Acid Antagonists (toxicity)
  • Excitatory Amino Acids (toxicity)
  • Immunohistochemistry
  • Mice
  • Oligodendroglia (drug effects, physiology)
  • Prosencephalon (cytology)
  • Quinoxalines (toxicity)
  • Receptors, AMPA (drug effects)
  • Receptors, Kainic Acid (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: